D-1743-2019 Class III Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

FDA drug recall D-1743-2019 was initiated by Glenmark Pharmaceuticals Inc., USA on Aug 7, 2019 and is designated Class III. Reason for recall: Temperature Abuse: Complaints received of liquidy texture. The recall status is terminated (terminated Nov 9, 2020). Affected quantity: 31,224 tubes.

Recall details

Product Type
Drugs
Report Date
Aug 21, 2019
Initiation Date
Aug 7, 2019
Termination Date
Nov 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31,224 tubes

Product description

Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Village: Kishanpura, Baddi Nalagarth Road, District: Solan, Himachal Pradesh-173205, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-298-17

Reason for recall

Temperature Abuse: Complaints received of liquidy texture.

Distribution pattern

Nationwide with the United States

Code information

Lot #: 05180734, Exp. 03/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1743-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1743-2019. Report a data issue: hello@regdatalab.com.